Antibody & TIDES Summit 2025
#TIDESxAB2025

Antibody Power Meets TIDES Precision: The Future of Biologics

Bringing together Antibody Engineering, TIDES of Innovation, and ADC Connect, the ANTIBODY & TIDES SUMMIT 2025 is where antibody power meets TIDES precision.

Amsterdam
9
-
10
September 2025
00
Days
00
Hours
00
Mins
00
Secs
150
+

Attendees

85
+

Companies

30
+

Speakers

16
+

Networking Hours

8
+

Case Studies

+

Interactive Sessions

About the Event

Coming together in an unprecedented event that will provide professionals with a comprehensive look at the most exciting developments in the biopharmaceutical industry, the Antibody & TIDES Summit 2025, will bring together senior leaders, top scientists, and decision-makers across peptide and oligonucleotide therapeutics, antibody engineering, and ADCs, offering a unique opportunity to address the latest challenges and advancements in biologic drug development, across three streams: 

  • TIDES of Innovation: The Pep & Oligos Summit 
  • Antibody Engineering: Engineering the Future of Therapeutic Antibodies
  • ADC Connect: The Science & Strategy of ADCs

As the biopharma sector evolves, peptide and oligonucleotide therapeutics, antibody engineering, and ADCs are emerging as key areas of innovation. The TIDES of Innovation programme will tackle challenges in synthesis, regulation, and commercialisation of peptides and oligonucleotides. Antibody Engineering will explore advances in antibody production, including manufacturing optimisation, automation, and regulatory compliance. ADC Connect will focus on designing next-gen ADCs, AI integration, clinical case studies, and manufacturing hurdles.

The event will also feature networking and exhibition sessions, offering opportunities to engage with industry leaders and explore new technologies. By combining these three programmes, the summit delivers a comprehensive look at the future of biologics, making it a must-attend for professionals in biopharmaceutical development.

By integrating these three focused programmes this event provides a unique, holistic view of the biologics sector. With cutting-edge content, unparalleled networking opportunities, and in-depth discussions on the challenges and innovations across multiple biologic modalities, this summit is essential for anyone looking to stay ahead in the rapidly advancing world of biopharmaceutical development. 

Agenda  at a Glance

View the Key Themes for

Antibody & TIDES Summit 2025

Antibody Engineering: Engineering the Future of Therapeutic Antibodies

Antibody engineering is revolutionising the treatment of complex diseases, such as cancer and autoimmune disorders. With the European market for monoclonal antibodies poised for significant growth, enhancing manufacturing processes has become more critical than ever. Antibody Engineering will provide a comprehensive platform for exploring the latest advancements in antibody production, including manufacturing optimisation, scale-up challenges, purification techniques, and regulatory compliance. Attendees will also engage in discussions around the integration of single-use technologies, automation, and computational approaches in antibody optimisation.

Day 1

  • Antibody Design & Engineering
  • Novel Approaches to Antibody Discovery
  • Computational Approaches & AI in Antibody Discovery
  • Emerging Modalities in Therapeutic Antibodies

Day 2

  • Process Development & Bioprocess Optimisation
  • Scale-Up & Single-Use Technologies
  • Automation & Advanced Analytics in Biomanufacturing
  • Downstream Processing & Purification

TIDES of Innovation: The Pep & Oligos Summit

As the biopharmaceutical landscape continues to evolve, peptide and oligonucleotide therapeutics are gaining unprecedented momentum. These complex molecules are at the forefront of the next generation of targeted therapies, offering promising treatments for a variety of diseases, including cancer, cardiovascular conditions, and rare genetic disorders. However, the path from discovery to market for these therapeutics is fraught with unique challenges, particularly in terms of synthesis, scalability, regulatory approval, and commercialisation. TIDES of Innovation will address these challenges through specialised, high-level discussions on optimising synthesis, navigating regulatory landscapes, and developing effective strategies for commercial scale-up.

Designed for those at the forefront of this rapidly growing sector, this programme will offer an intimate setting for deep-dive conversations and networking opportunities:

Day 1

  • Emerging Trends in Peptide & Oligonucleotide Therapeutics
  • Advances in Peptide Synthesis & Manufacturing
  • Quality by Design (QbD) in Peptide & Oligonucleotide Manufacturing
  • Challenges in Oligonucleotide Drug Delivery

Day 2

  • Regulatory Pathways for Peptide & Oligonucleotide Drugs
  • Clinical Development of Oligonucleotide Therapeutics
  • Stability & Efficacy in Peptide Drugs
  • Supply Chain & Logistics Management

ADC Connect: The Science & Strategy of ADCs

ADC Connect focuses specifically on the rapidly-advancing field of antibody drug conjugates, covering critical topics in the design and engineering of ADCs, such as optimising payload-linker technologies and exploring novel ADC payloads to expand therapeutic potential.

The agenda will also address the integration of AI and computational tools in ADC development, along with next-generation ADCs and the promise of combination therapies. Regulatory considerations for ADC development, clinical development case studies, and the stability, safety, and pharmacokinetics of ADCs will also be discussed.

Manufacturing challenges and supply chain solutions for ADCs will be key themes, ensuring that participants are equipped with the insights needed to overcome the complex challenges in ADC production:

Day 1

  • ADC Design & Engineering: Optimising Payload-Linker Technologies​
  • Novel ADC Payloads: Expanding Therapeutic Potential​
  • AI & Computational Tools in ADC Development​
  • Emerging Modalities: Next-Generation ADCs and Combination Therapies​

Day 2​

  • Regulatory Considerations for ADC Development & Approval​
  • Clinical Development & Trials: ADC Case Studies​
  • ADC Stability, Safety, & Pharmacokinetics​
  • Manufacturing Challenges & Supply Chain Solutions for ADCs​

Ready to attend?

Register today to secure your ticket.

Speakers

Esteemed Voices From the Industry

Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.

Dr Angel Eduardo Santorelli Villamizar
Dr Angel Eduardo Santorelli Villamizar
Oligonucleotide and Organic Synthesis Chemist
ETH
Dr Petra Disterer
Dr Petra Disterer
Senior Scientist/ Science Writer
University College London
Dr Vusala Ibrahimova
Dr Vusala Ibrahimova
Research Scientist
Curevac
Germany
Dr Anders Gabrielsen
Dr Anders Gabrielsen
VP & Head of Global Clinical Development
Ribocure Pharmaceuticals AB
Sweden
Dr David Gilot
Dr David Gilot
Director
AstraZeneca
Sweden
Dr Fernando Albericio
Dr Fernando Albericio
Research Professor
University of Kwa-Zulu Natal
South Africa
Dr Driton Vllasaliu
Dr Driton Vllasaliu
MPharm Course Director
King's College London
United Kingdom
Nathan Robertson
Nathan Robertson
Director of Biologics Discovery & Development
LifeArc
United Kingdom
Michael Mullin
Michael Mullin
Head of Antibody Engineering
LabGenius
United Kingdom

Registration

Choose a plan that fits your role, company, and industry.

BIG PHARMA
£2150 + VAT

Early Bird

VAT exemptions will be applied where applicable in accordance with relevant regulations.

For Companies Outside Singapore
Get Started
For Singapore-Based Companies
Get started
BIOPHARMA & ACADEMIC
£1050 + VAT

Early Bird

VAT exemptions will be applied where applicable in accordance with relevant regulations.

For Companies Outside Singapore
Get Started
For Singapore-Based Companies
Get started
SERVICE & SOLUTION PROVIDERS
Attendance Only

Representatives of service, solution, and technology providers are welcome to attend the Antibody & TIDES Summit 2025

Get in touch with us today for detailed information on attendee options, sponsorship opportunities and benefits, and how to maximise your presence at #TIDESxAB2025

For Companies Outside Singapore
Get Started
For Singapore-Based Companies
Get started

Registration

Register Your Interest

Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
 

Get Started

Want to Speak at This Event?

Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.

Principle

Platinum

No items found.

Gold

No items found.

Silver

No items found.

Bronze

No items found.

Exhibition & Showcase

Associate

No items found.

Media & Publicity

No items found.

Pre Conference Workshops & Other Sessions

Visit the event page to view more content.

No items found.

Awards Cerermony

Visit the awards page to view more content.

Frequently Asked Questions

How can I stay updated on event details and announcements?

To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.

What can I expect to learn and explore during the event?

The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.

What safety measures will be in place to ensure the safety of attendees?

We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.

Is there a cancellation or refund policy if I can't attend after registering?

Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.

Can I submit a presentation to be a speaker at this event?

We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.

What type of professionals benefit most from attending?

Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.

What advantages does this conference offer participants?

Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals

Are there networking opportunities or special events planned?

Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.

Are there sponsorship opportunities for this event?

Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.

How can I register for the event?

To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.

Be a Part of This Event!

Don't miss out on unique networking, speaking and sponsorship opportunities.

Concept
Speakers
Registration
Partners
Content
Code: